IFI16 and esophageal squamous cell carcinoma: Mechanistically, IFI16-induced IL-1α has been shown to exacerbate the malignant phenotype of ESCC cells, with particular impacts on cell survival and migration, thus contributing to disease progression (Figure 4, right panels) (126).